x

Xilio Therapeutics, Inc. (Nasdaq:XLO)

Health Care/Life Sciences • Biotechnology
CIK 1840233
Company

Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.

Address
828 Winter Street
Suite 300
Waltham, Massachusetts 02451
Employees
89
Stock Info
Close
$0.7942
Day Range
0.7105 - 0.8130
52 Week Range
0.4900 - 3.6700
Average volume
209.81K
Short Interest
33.75K (02/15/24)
% of Float Shorted
0.24%
Market Cap
$20.1M
Revenue
N/A
Net Income
N/A
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$2.9580
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Independent Director
Yuan J Xu PhD
Independent Director
Daniel Curran MD, MBA
Independent Director
Christina Rossi MBA
Independent Director
Tomas Jan Heyman
Independent Director
Robert W Ross MD
Independent Director
Sara M Bonstein MBA
SEC filings
DateFormEvent
8 Aug, 2024 8-K
8 Aug, 2024 10-Q
6 Aug, 2024 4
31 Jul, 2024 SC 13G/A
17 Jun, 2024 4
17 Jun, 2024 4
17 Jun, 2024 4
17 Jun, 2024 4
17 Jun, 2024 4
17 Jun, 2024 4
17 Jun, 2024 4
17 Jun, 2024 4
17 Jun, 2024 8-K
17 Jun, 2024 3
17 Jun, 2024 3
13 Jun, 2024 8-K
14 May, 2024 10-Q
14 May, 2024 8-K
6 May, 2024 EFFECT
3 May, 2024 4
3 May, 2024 4
3 May, 2024 4
3 May, 2024 4
2 May, 2024 UPLOAD
2 May, 2024 CORRESP
30 Apr, 2024 S-3
25 Apr, 2024 ARS
25 Apr, 2024 DEF 14A
25 Apr, 2024 DEFA14A
15 Apr, 2024 424B5
5 Apr, 2024 SC 13G
5 Apr, 2024 SC 13G/A
3 Apr, 2024 3
3 Apr, 2024 4
1 Apr, 2024 10-K
1 Apr, 2024 8-K
1 Apr, 2024 S-8
28 Mar, 2024 8-K
28 Mar, 2024 8-K
14 Feb, 2024 SC 13G
9 Feb, 2024 4
6 Feb, 2024 SC 13G/A
5 Feb, 2024 SC 13G/A
16 Jan, 2024 4
3 Jan, 2024 4
3 Jan, 2024 4
3 Jan, 2024 8-K
3 Jan, 2024 4
3 Jan, 2024 4
7 Dec, 2023 8-K
9 Nov, 2023 10-Q
9 Nov, 2023 8-K
9 Nov, 2023 10-K/A
9 Nov, 2023 10-Q/A
9 Nov, 2023 10-Q/A
3 Nov, 2023 8-K
7 Sep, 2023 3
7 Sep, 2023 4
5 Sep, 2023 8-K CEO Change
18 Aug, 2023 4
18 Aug, 2023 4
18 Aug, 2023 4
18 Aug, 2023 4
14 Aug, 2023 10-Q
14 Aug, 2023 8-K
7 Aug, 2023 4
7 Aug, 2023 3
3 Aug, 2023 8-K
13 Jun, 2023 4
13 Jun, 2023 4
13 Jun, 2023 8-K
13 Jun, 2023 4
13 Jun, 2023 4
13 Jun, 2023 4
13 Jun, 2023 4
25 May, 2023 8-K
9 May, 2023 10-Q
9 May, 2023 8-K
25 Apr, 2023 ARS
25 Apr, 2023 DEFA14A
25 Apr, 2023 DEF 14A
10 Apr, 2023 SC 13G
3 Apr, 2023 4
3 Apr, 2023 3
3 Apr, 2023 8-K
2 Mar, 2023 S-8
2 Mar, 2023 8-K
2 Mar, 2023 10-K
9 Feb, 2023 SC 13G/A
25 Jan, 2023 SC 13G
9 Jan, 2023 8-K
4 Jan, 2023 4
4 Jan, 2023 4
4 Jan, 2023 4
29 Dec, 2022 SC 13G/A
23 Dec, 2022 8-K
18 Nov, 2022 EFFECT
16 Nov, 2022 3
16 Nov, 2022 CORRESP
15 Nov, 2022 UPLOAD
14 Nov, 2022 SC 13G/A
9 Nov, 2022 8-K
9 Nov, 2022 10-Q
9 Nov, 2022 S-3
16 Sep, 2022 3
16 Sep, 2022 4
15 Sep, 2022 8-K
9 Aug, 2022 10-Q
9 Aug, 2022 8-K
28 Jul, 2022 8-K
23 Jun, 2022 4/A
17 Jun, 2022 4
17 Jun, 2022 3
17 Jun, 2022 4
17 Jun, 2022 4
17 Jun, 2022 4
17 Jun, 2022 4
17 Jun, 2022 4
17 Jun, 2022 4
16 Jun, 2022 8-K
13 Jun, 2022 8-K
12 May, 2022 8-K
12 May, 2022 10-Q
26 Apr, 2022 DEFA14A
26 Apr, 2022 DEF 14A
1 Mar, 2022 10-K
1 Mar, 2022 8-K
1 Mar, 2022 S-8
24 Feb, 2022 4
24 Feb, 2022 4
24 Feb, 2022 4
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
11 Feb, 2022 SC 13G/A
9 Feb, 2022 SC 13G/A
4 Feb, 2022 8-K
14 Jan, 2022 SC 13G
6 Jan, 2022 3
6 Jan, 2022 8-K
6 Jan, 2022 4
4 Jan, 2022 4/A
23 Dec, 2021 4
10 Dec, 2021 4
2 Dec, 2021 10-Q
2 Dec, 2021 8-K
5 Nov, 2021 SC 13D
5 Nov, 2021 SC 13G
5 Nov, 2021 SC 13G
5 Nov, 2021 3
5 Nov, 2021 SC 13G
4 Nov, 2021 SC 13G
3 Nov, 2021 4/A
3 Nov, 2021 SC 13D
28 Oct, 2021 4
28 Oct, 2021 4
28 Oct, 2021 4
28 Oct, 2021 4
27 Oct, 2021 SC 13G
26 Oct, 2021 4
26 Oct, 2021 8-K
26 Oct, 2021 4
26 Oct, 2021 4
26 Oct, 2021 4
26 Oct, 2021 4
26 Oct, 2021 4
26 Oct, 2021 4
26 Oct, 2021 4
25 Oct, 2021 4
25 Oct, 2021 4
25 Oct, 2021 4
25 Oct, 2021 4
25 Oct, 2021 S-8
22 Oct, 2021 SEC STAFF
22 Oct, 2021 3
22 Oct, 2021 424B4 IPO completed
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 EFFECT
21 Oct, 2021 CERT
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
21 Oct, 2021 3
20 Oct, 2021 S-1/A
19 Oct, 2021 CORRESP
19 Oct, 2021 CORRESP
18 Oct, 2021 CORRESP
18 Oct, 2021 S-1/A
18 Oct, 2021 8-A12B
13 Oct, 2021 UPLOAD
1 Oct, 2021 CORRESP
1 Oct, 2021 S-1
23 Sep, 2021 UPLOAD
14 Sep, 2021 DRSLTR
14 Sep, 2021 DRS/A
25 Jun, 2021 SEC STAFF
21 Jun, 2021 UPLOAD
24 May, 2021 DRS
26 Feb, 2021 D
21 Jan, 2021 D
Last update:2024-03-06 13:16:12.294600
Xilio Therapeutics, Inc. by TradingView

Sign Up to Subscribe